135.42
price up icon0.34%   0.46
after-market Dopo l'orario di chiusura: 135.42
loading

Neurocrine Biosciences Inc Azioni (NBIX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
0.02%
515.30
515.20 498.80 452.70 420.40
Cost Of Revenue
11.76%
7.50
8.50 11.20 11.50 8.50
Gross Profit
0.22%
507.80
506.70 487.60 441.20 411.90
Operating Expenses
14.62%
408.50
356.40 346.40 367.60 526.10
Interest Income/Expense
0.00%
1.10
1.10 1.10 1.30 1.10
Benefits Costs and Expenses
51.67%
480.80
317.00 383.20 331.10 523.70
Costs And Expenses
14.00%
416.00
364.90 357.60 379.10 534.60
Operating Income/Loss
33.93%
99.30
150.30 141.20 73.60 -114.20
Nonoperating Income/Loss
235.28%
-64.80
47.90 -25.60 48.00 10.90
Income/Loss From Continuing Operations Before Tax
82.59%
34.50
198.20 115.60 121.60 -103.30
Income Tax Expense/Benefit
117.62%
-8.90
50.50 32.50 26.10 -26.70
Income/Loss From Continuing Operations After Tax
70.62%
43.40
147.70 83.10 95.50 -76.60
Net Income/Loss
70.62%
43.40
147.70 83.10 95.50 -76.60
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
49,800%
99.80
0.20 97.90 97.60 97.10
Diluted Average Shares
25,800%
103.60
0.40 101.10 100.20 97.10
Basic Earnings Per Share
71.52%
0.43
1.51 0.85 0.98 -0.79
Diluted Earnings Per Share
71.23%
0.42
1.46 0.82 0.95 -0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_specialty_generic RDY
$15.37
price up icon 1.65%
$12.52
price up icon 3.22%
$83.45
price down icon 0.82%
$89.28
price down icon 2.89%
$11.63
price down icon 1.61%
Capitalizzazione:     |  Volume (24 ore):